FDA Investigator Kenneth V Miller
Kenneth V Miller has inspections in 3 countries as of 27 Oct 2023. Kenneth V Miller has collaborated with a combined 1179 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Japan,
Ireland,
United States of America
Co-Investigator(s):
Anthony Abel,
Anthony J Lagreca,
Ashar P Parikh,
Barbara Jwilimczyk Macri,
Bryce A Hammer,
CDR Ileana Barreto Pettit,
Cheryl A Clausen,
Erika V Butler,
Erin D Mccaffery,
Farhana Khan,
Frank L Cordova,
Frederick L Fricke,
George J Flynn,
Ginger M Sykes,
Grace E Mcnally,
Haroon Vohra (NMI),
Isabel Y Espinosa,
Israel Santiago, OCM,
Jamie L Dion,
Janet L Bowen,
Javier O Vega,
Jennifer D Hollstrom,
Jose R Hernandez,
Joshua P Wireman,
Justin R Carr,
Karen A Wolnik,
Karen G Hirshfield,
Katherine Szestypalow,
Kenneth Miller,
Kent C Faul,
Kimberley A Hoefen,
Kristy A Zielny,
LCDR Michael H Tollon,
Linda M Cheny,
Linda Thai,
Matt D Suedkamp,
Matthew B Casale,
Matthew J Hansen,
Matthew R Dionne,
Michael A Charles,
Michael J Kuchta,
Michael Kuchta,
Michael R Goga,
Michele L Obert,
Mra Mcculloughj,
Nancy G Schmidt,
Nathan M Jornod,
Nayan J Patel,
Patricia A Brown,
Patricia A Cortez,
Patricia Brown,
Patricia H Dlugosz,
Rebecca H Lee,
Richmond K Yip,
Robert Sharpnack,
Shirley H Isbill,
Sue Lee Chan,
Susan F Laska, MS,
Susan W Ting,
Tenzin Jangchup,
Terri L Dodds,
Thai T Duong,
Theressa B Smith,
Tonya R Johnson,
Yuesheng Ye,
Zachary A Bogorad,
Zachary L Miller,
Zachary L Stamm
Kenneth V Miller's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2008 | FDA 483 Response | Sandoz Incorporated - Form 483R, 2008-08-01 |
November, 2004 | FDA 483 Response | Astellas Pharma Inc. - Form 483R, 2005-01-03 |
July, 2008 | EIR | Sandoz Incorporated - EIR, 2008-07-03 |
November, 2004 | EIR | Astellas Pharma Inc. - EIR, 2004-12-16 |
July, 2008 | FDA 483 | Sandoz Incorporated - Form 483, 2008-07-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more